1.Grubbs, RD, Maguire, ME. Magnesium as a regulatory cation: criteria and evaluation. Magnesium 1987;6:113–127.
2.Saris, NE, Mervaala, E, Karppanen, H, Khawaja, JA, Lewenstam, A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1–26.
3.Wolf, FI, Trapani, V, Cittadini, A. Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnes Res 2008;21:83–91.
4.Barbagallo, M, Dominguez, LJ. Magnesium and aging. Curr Pharm Des 2010;16:832–839.
5.Ryan, MF. The role of magnesium in clinical biochemistry: an overview. Ann Clin Biochem 1991;28(Pt 1):19–26.
6.Koenig, JH, Ikeda, K. Synaptic vesicles have two distinct recycling pathways. J Cell Biol 1996;135:797–808.
7.Zarate, CA Jr., Du, J, Quiroz, Jet al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci 2003;1003:273–291.
8.Murck, H. Magnesium and affective disorders. Nutr Neurosci 2002;5:375–389.
9.Rasmussen, HH, Mortensen, PB, Jensen, IW. Depression and magnesium deficiency. Int J Psychiatry Med 1989;19:57–63.
10.Levine, J, Stein, D, Rapoport, A, Kurtzman, L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 1999;39:63–70.
11.Cox, IM, Campbell, MJ, Dowson, D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991;337:757–760.
12.Barragan-Rodriguez, L, Rodriguez-Moran, M, Guerrero-Romero, F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 2008;21:218–223.
13.Chaudhary, DP, Sharma, R, Bansal, DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 2010;134:119–129.
14.Celik, N, Andiran., N, Yilmaz, AE. The relationship between serum magnesium levels with childhood obesity and insulin resistance: a review of the literature. J Pediatr Endocrinol Metab 2011;24:675–678.
15.Garfinkel, D, Garfinkel, L. Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 1988;7:249–261.
16.Suarez, A, Pulido, N, Casla, A, Casanova, B, Arrieta, FJ, Rovira, A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995;38:1262–1270.
17.Nadler, JL, Buchanan, T, Natarajan, R, Antonipillai, I, Bergman, R, Rude, R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024–1029.
18.Paolisso, G, Sgambato, S, Giugliano, Det al. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988;31:910–915.
19.Weglicki, WB, Phillips, TM, Freedman, AM, Cassidy, MM, Dickens, BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992;110:169–173.
20.Pachikian, BD, Neyrinck, AM, Deldicque, Let al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr 2010;140:509–514.
21.Collins, SM, Kassam, Z, Bercik, P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 2013;16:240–245.
22.Bangsgaard Bendtsen, KM, Krych, L, Sorensen, DBet al. Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PloS One 2012;7:e46231.
23.Cryan, JF, Dinan, TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701–712.
24.Cryan, JF, O’Mahony, SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011;23:187–192.
25.Johnson, S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001;56:163–170.
26.Kantak, KM. Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci 1988;102:304–311.
27.Singewald, N, Sinner, C, Hetzenauer, A, Sartori, SB, Murck, H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice–influence of desipramine and Hypericum perforatum extract. Neuropharmacology 2004;47:1189–1197.
28.Porsolt, RD, Le Pichon, M, Jalfre, M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730–732.
29.Pyndt, JBHJ, Krych, L, Larsen, Cet al. A possible link between food and mood: dietary impact on gut microbiota and behavior in balb/c mice. PloS One 2014;9:1–15.
30.Elfving, B, Bonefeld, BE, Rosenberg, R, Wegener, G. Differential expression of synaptic vesicle proteins after repeated electroconvulsive seizures in rat frontal cortex and hippocampus. Synapse 2008;62:662–670.
31.Andersen, CL, Jensen, JL, Orntoft, TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245–5250.
32.Lundberg, R, Clausen, SK, Pang, Wet al. Gastrointestinal microbiota and local inflammation during oxazolone-induced dermatitis in BALB/cA mice. Comp Med 2012;62:371–380.
33.Muyzer, G, Smalla, K. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek 1998;73:127–141.
34.Decollogne, S, Tomas, A, Lecerf, C, Adamowicz, E, Seman, M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol, Biochem Behav 1997;58:261–268.
35.Poleszak, E, Szewczyk, B, K’dzierska, E, Wlaź, P, Pilc, A, Nowak, G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 2004;78:7–12.
36.Eby, GA, Eby, KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006;67:362–370.
37.Crunelli, V, Mayer, ML. Mg2+ dependence of membrane resistance increases evoked by NMDA in hippocampal neurones. Brain Res 1984;311:392–396.
38.Ennis, M, Aston-Jones, G, Shiekhattar, R. Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 1992;598:185–195.
39.Shiekhattar, R, Aston-Jones, G. NMDA-receptor-mediated sensory responses of brain noradrenergic neurons are suppressed by in vivo concentrations of extracellular magnesium. Synapse 1992;10:103–109.
40.Whittle, N, Li, L, Chen, WQet al. Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids 2011;40:1231–1248.
41.Tizabi, Y, Bhatti, BH, Manaye, KF, Das, JR, Akinfiresoye, L. Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female wistar-kyoto rats. Neuroscience 2012;72–80.
42.Sartori, SB, Whittle, N, Hetzenauer, A, Singewald, N. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology 2012;62:304–312.
43.Poleszak, E, Szewczyk, B, Kedzierska, E, Wlaz, P, Pilc, A, Nowak, G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol, Biochem Behav 2004;78:7–12.
44.Boadle-Biber, MC. Activation of tryptophan hydroxylase from central serotonergic neurons by calcium and depolarization. Biochem Pharmacol 1978;27:1069–1079.
45.Cao, BJ, Peng, NA. Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents. Eur J Pharmacol 1993;237:177–181.
46.Djurhuus, MS, Klitgaard, NA, Beck-Nielsen, H. Magnesium deficiency and development of late diabetic complications. Ugeskr Laeger 1991;153:2108–2110.
47.Turnbaugh, PJ, Ley, RE, Mahowald, MA, Magrini, V, Mardis, ER, Gordon, JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027–1031.
48.O’Mahony, SM, Marchesi, JR, Scully, Pet al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009;65:263–267.
49.Collins, S, Verdu, E, Denou, E, Bercik, P. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis 2009;27(Suppl. 1):85–89.
50.Desbonnet, L, Garrett, L, Clarke, G, Kiely, B, Cryan, JF, Dinan, TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010;170:1179–1188.
51.Cryan, JF, Markou, A, Lucki, I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002;23:238–245.
52.Petit-Demouliere, B, Chenu, F, Bourin, M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacol (Berl) 2005;177:245–255.
53.Wu, TH, Lin, CH. IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res 2008;193:183–191.
54.Baticic, L, Detel, D, Kucic, N, Buljevic, S, Pugel, EP, Varljen, J. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice. J Cell Biochem 2011;112:3322–3333.
55.Kanarik, M, Alttoa, A, Matrov, Det al. Brain responses to chronic social defeat stress: effects on regional oxidative metabolism as a function of a hedonic trait, and gene expression in susceptible and resilient rats. Eur Neuropsychopharmacol 2011;21:92–107.
56.Iosifescu, DV, Bolo, NR, Nierenberg, AA, Jensen, JE, Fava, M, Renshaw, PF. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry 2008;63:1127–1134.
57.Moles, KW, McMullen, JK. Insulin resistance and hypomagnesaemia: case report. Br Med J (Clin Res Ed) 1982;285(6337):262.
58.Kandeel, FR, Balon, E, Scott, S, Nadler, JL. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 1996;45:838–843.